I agree it is positive re the safety profile but also agree that the announcement could be clearer and more informative.
Advancement to 35 mg/m2 was announced in August 2020, so does that mean it will be another 8 months before we hear anything about the safety of 45 mg/m2? If so, how many dose ranges are they testing before they can move on to phase 2?
Has the company commented on any of this previously?
PTX Price at posting:
10.5¢ Sentiment: Hold Disclosure: Held
